EZH2 and triple-negative breast carcinoma: Compared with normal or benign hyperplastic lobules and ducts, EZH2 expression was elevated in high-grade DCIS adjacent to triple-negative breast carcinoma (0 versus 90 %, p < 0.001) (Table 4).